DK0526171T3 - Krystaller af N-(trans-4-isopropylcyclohexylcarbonyl)-Dphenylalanin og fremgangsmåder til fremstilling deraf - Google Patents
Krystaller af N-(trans-4-isopropylcyclohexylcarbonyl)-Dphenylalanin og fremgangsmåder til fremstilling derafInfo
- Publication number
- DK0526171T3 DK0526171T3 DK92306895.1T DK92306895T DK0526171T3 DK 0526171 T3 DK0526171 T3 DK 0526171T3 DK 92306895 T DK92306895 T DK 92306895T DK 0526171 T3 DK0526171 T3 DK 0526171T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystals
- isopropylcyclohexylcarbonyl
- phenylalanine
- trans
- solvent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18969691 | 1991-07-30 | ||
JP19945391 | 1991-08-08 | ||
CA002114678A CA2114678C (en) | 1991-07-30 | 1994-02-01 | Crystals of n-(trans-4-isopropylcyclohexylcarbonyl)- d-phenylalanine and methods for preparing them |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0526171T3 true DK0526171T3 (da) | 1997-08-25 |
Family
ID=27169694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92306895.1T DK0526171T3 (da) | 1991-07-30 | 1992-07-29 | Krystaller af N-(trans-4-isopropylcyclohexylcarbonyl)-Dphenylalanin og fremgangsmåder til fremstilling deraf |
Country Status (11)
Country | Link |
---|---|
US (1) | US5488150A (da) |
EP (1) | EP0526171B1 (da) |
JP (1) | JP2508949B2 (da) |
AT (1) | ATE149483T1 (da) |
BR (1) | BR1100807A (da) |
CA (1) | CA2114678C (da) |
DE (2) | DE10199058I2 (da) |
DK (1) | DK0526171T3 (da) |
ES (1) | ES2100291T3 (da) |
LU (2) | LU90843I2 (da) |
NL (1) | NL300063I2 (da) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE322260T1 (de) | 1996-11-15 | 2006-04-15 | Ajinomoto Kk | Nateglinide zubereitung in tablettenform |
GB9713730D0 (en) | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
US6878749B2 (en) * | 1999-09-17 | 2005-04-12 | Novartis Ag | Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
US6559188B1 (en) | 1999-09-17 | 2003-05-06 | Novartis Ag | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes |
AR028299A1 (es) | 1999-09-17 | 2003-05-07 | Novartis Ag | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. |
DK1741445T3 (da) | 2000-01-21 | 2013-11-04 | Novartis Ag | Kombinationer omfattende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler |
AR033390A1 (es) | 2000-08-22 | 2003-12-17 | Novartis Ag | Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes |
AU2001294265A1 (en) * | 2000-10-18 | 2002-04-29 | Ajinomoto Co., Inc. | Process for producing nateglinide crystal |
CA2425533C (en) * | 2000-10-18 | 2010-04-20 | Ajinomoto Co., Inc. | Methods for producing acylphenylalanine |
CA2426263C (en) * | 2000-10-24 | 2010-05-25 | Ajinomoto Co., Inc. | Nateglinide-containing preparation |
CA2426745C (en) * | 2000-10-24 | 2009-09-15 | Ajinomoto Co., Inc. | Methods for producing nateglinide b-type crystals |
WO2002040010A1 (fr) * | 2000-10-24 | 2002-05-23 | Ajinomoto Co.,Inc. | Preparations de medicament contenant du nateglinide |
AR035425A1 (es) * | 2001-01-30 | 2004-05-26 | Teijin Ltd | Cristal de diclorhidrato del acido 3-(3-amidinofenil)-5-[({[1-(iminoetil)-4-piperidil]metil}amino)metil]benzoico y proceso para prepararlo |
EP1435912A4 (en) * | 2001-09-12 | 2005-03-30 | Alembic Ltd | NOVEL STABLE CRYSTAL FORM OF N- (TRANS-4-ISOPROPYLCYCLOHEXYL CARBONYL) -D-PHENYLALANINE AND PREPARATION METHOD THEREOF |
TW200304813A (en) * | 2002-03-11 | 2003-10-16 | Novartis Ag | Salts of organic acid |
US7247746B2 (en) * | 2002-04-15 | 2007-07-24 | Novartis, Ag | Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine |
AU2003236243A1 (en) * | 2002-04-15 | 2003-10-27 | Ajinomoto Co., Inc. | Novel nateglinide crystal |
US7411089B2 (en) | 2002-04-15 | 2008-08-12 | Ajinomoto Co., Inc. | Nateglinide crystals |
CA2481322A1 (en) * | 2002-04-29 | 2003-11-13 | Biocon Limited | Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine |
US6861553B2 (en) * | 2002-07-03 | 2005-03-01 | Teva Pharmaceuticals Industries Ltd. | Process for preparing nateglinide and intermediates thereof |
CN100384813C (zh) * | 2002-07-03 | 2008-04-30 | 特瓦制药工业有限公司 | 制备那格列奈及其中间体的方法 |
US7358390B2 (en) * | 2002-07-18 | 2008-04-15 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of nateglinide |
US20050075400A1 (en) * | 2002-07-18 | 2005-04-07 | Ronit Yahalomi | Polymorphic forms of nateglinide |
US7534913B2 (en) * | 2002-07-18 | 2009-05-19 | Teva Pharmaceutica Industries Ltd. | Crystalline form of nateglinide |
US7420084B2 (en) * | 2002-07-18 | 2008-09-02 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of nateglinide |
US7148376B2 (en) * | 2002-07-18 | 2006-12-12 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of nateglinide |
WO2004020396A1 (en) * | 2002-08-28 | 2004-03-11 | Dr. Reddy's Laboratories Limited | Crystalline form of nateglinide and process for preparation thereof |
EP1616886A4 (en) * | 2003-02-18 | 2006-06-14 | Konishi Co Ltd | CURABLE RESIN, PROCESS FOR PRODUCING THE SAME, AND CURABLE RESIN COMPOSITION |
HU227073B1 (hu) * | 2003-07-10 | 2010-06-28 | Richter Gedeon Nyrt | Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenil-alanin (nateglinid) és kristálymódosulatainak elõállítására, valamint a G-kristálymódosulata |
US20060004102A1 (en) * | 2004-05-07 | 2006-01-05 | Shlomit Wizel | Polymorphic forms of nateglinide |
US7425648B2 (en) | 2005-01-03 | 2008-09-16 | A.M.S.A. Anonima Materie Sintetiche E. Affini S.P.A. | Process for the preparation of nateglinide, preferably in B-form |
GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
CN102908350B (zh) | 2005-09-14 | 2014-07-23 | 武田药品工业株式会社 | 用于治疗糖尿病的二肽基肽酶抑制剂 |
CN101415668B (zh) * | 2006-03-31 | 2013-06-19 | 味之素株式会社 | 羧酸酰氯化合物的制造方法 |
PT2091910E (pt) * | 2006-12-06 | 2014-11-18 | Conatus Pharmaceuticals Inc | Formas cristalinas do ácido (3s)-3-[n-(n¿-(2-tercbutilfenil) oxamil)alaninil]amino-5-(2¿,3¿,5¿,6¿- tetrafluorofenoxi)-4-oxopentanóico |
PE20120403A1 (es) | 2009-05-15 | 2012-05-03 | Novartis Ag | Aril-piridinas como inhibidoras de sintasa de aldosterona |
WO2010136474A2 (en) | 2009-05-28 | 2010-12-02 | Novartis Ag | Substituted aminobutyric derivatives as neprilysin inhibitors |
UY32662A (es) | 2009-05-28 | 2010-12-31 | Novartis Ag | Derivados amino-propionicos sustituidos como inhibidores de neprilisina |
WO2011041293A1 (en) | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors |
EP2993169B1 (en) | 2009-11-17 | 2017-12-20 | Novartis AG | Aryl-pyridine derivatives as aldosterone synthase inhibitors |
JO2967B1 (en) | 2009-11-20 | 2016-03-15 | نوفارتس ايه جي | Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors |
EP2507234B1 (en) | 2009-11-30 | 2014-03-12 | Novartis AG | Imidazole derivatives as aldosterone synthase inhibitors |
RS53176B (en) | 2010-02-03 | 2014-06-30 | Takeda Pharmaceutical Company Limited | KINASE INHIBITORS 1 REGULATING SIGNALS IN APOPTOSIS |
US8673974B2 (en) | 2010-11-16 | 2014-03-18 | Novartis Ag | Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors |
US8877815B2 (en) | 2010-11-16 | 2014-11-04 | Novartis Ag | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP |
UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
US9163040B2 (en) | 2013-02-14 | 2015-10-20 | Novartis Ag | Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors |
CA2918077A1 (en) | 2013-07-25 | 2015-01-29 | Novartis Ag | Bioconjugates of synthetic apelin polypeptides |
MX2016001020A (es) | 2013-07-25 | 2016-08-03 | Novartis Ag | Polipeptidos ciclicos para el tratamiento de insuficiencia cardiaca. |
BR112017014194A2 (pt) | 2015-01-23 | 2018-01-09 | Novartis Ag | conjugados de ácido graxo de apelina sintéticos com meia-vida melhorada |
UY38072A (es) | 2018-02-07 | 2019-10-01 | Novartis Ag | Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos |
CN109369443A (zh) * | 2018-11-05 | 2019-02-22 | 扬子江药业集团江苏海慈生物药业有限公司 | 一种新的那格列奈h晶型的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US196222A (en) * | 1877-10-16 | Improvement in belt-tighteners | ||
JPS6354321A (ja) * | 1985-03-27 | 1988-03-08 | Ajinomoto Co Inc | 血糖降下剤 |
-
1992
- 1992-07-29 EP EP92306895A patent/EP0526171B1/en not_active Expired - Lifetime
- 1992-07-29 AT AT92306895T patent/ATE149483T1/de active
- 1992-07-29 DE DE2001199058 patent/DE10199058I2/de active Active
- 1992-07-29 DK DK92306895.1T patent/DK0526171T3/da active
- 1992-07-29 ES ES92306895T patent/ES2100291T3/es not_active Expired - Lifetime
- 1992-07-29 DE DE69217762T patent/DE69217762T2/de not_active Expired - Lifetime
- 1992-07-29 JP JP4202686A patent/JP2508949B2/ja not_active Expired - Lifetime
-
1993
- 1993-12-14 US US08/166,144 patent/US5488150A/en not_active Expired - Lifetime
-
1994
- 1994-02-01 CA CA002114678A patent/CA2114678C/en not_active Expired - Lifetime
-
1997
- 1997-05-12 BR BR1100807-5A patent/BR1100807A/pt active IP Right Grant
-
2001
- 2001-09-28 NL NL300063C patent/NL300063I2/nl unknown
- 2001-09-28 LU LU90843C patent/LU90843I2/fr unknown
- 2001-10-03 LU LU90846C patent/LU90846I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
NL300063I2 (nl) | 2002-02-01 |
EP0526171A2 (en) | 1993-02-03 |
ATE149483T1 (de) | 1997-03-15 |
JP2508949B2 (ja) | 1996-06-19 |
BR1100807A (pt) | 1999-12-28 |
DE69217762D1 (de) | 1997-04-10 |
US5488150A (en) | 1996-01-30 |
EP0526171A3 (en) | 1993-05-05 |
LU90843I2 (fr) | 2002-02-04 |
NL300063I1 (nl) | 2001-12-01 |
DE69217762T2 (de) | 1997-10-09 |
EP0526171B1 (en) | 1997-03-05 |
DE10199058I2 (de) | 2006-04-27 |
CA2114678C (en) | 1999-04-27 |
ES2100291T3 (es) | 1997-06-16 |
CA2114678A1 (en) | 1995-08-02 |
LU90846I2 (fr) | 2002-02-04 |
JPH05208943A (ja) | 1993-08-20 |
DE10199058I1 (de) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0526171T3 (da) | Krystaller af N-(trans-4-isopropylcyclohexylcarbonyl)-Dphenylalanin og fremgangsmåder til fremstilling deraf | |
DK0581216T3 (da) | Fremgangsmåde til fremstilling af titanoxidcoatingsfilm | |
PT99261A (pt) | Processo para a preparacao de herbicidas a base de aril-haloalquilpirazoles substituidos | |
DK15589D0 (da) | Kemiske forbindelser | |
ES2023509B3 (es) | Producto granular (i). | |
DK0596692T3 (da) | Fremgangsmåder til fremstilling af (E)-alkoxyimino- eller hydroxyiminoacetamidforbindelser og mellemprodukter dertil | |
EP0259188A3 (en) | Polyarylene thioether of high crystallizing rate and a process for producing the same | |
TR24452A (tr) | Pestisidler ve bitki bueyueme duezenleyicileri olarak heterosiklik dionlar | |
FI895185A0 (fi) | Mevalonolaktoner av tienopyridintyp. | |
DE2860988D1 (en) | Process for the fractional desublimation of dianhydride of 1,2,4,5-benzenetetracarboxylic acid | |
FI883961A0 (fi) | Farmaceutiskt nyttig polymorfisk modifikation av buspiron. | |
DE69012409D1 (de) | Vorrichtung zur Herstellung von Halbleitern durch Abscheidung aus der Gasphase. | |
ES2143459T3 (es) | 4,5-dihidro-1h-pirazol-1-carboxamidas n-aril-3-aril-4 sustituidas y procedimientos para su produccion. | |
NO175776C (no) | 1-aminopropandiol-2,3 med höy renhet, samt fremgangsmåte for fremstilling av forbindelsen | |
WO2005019147A3 (en) | Pesticidally active phenol derivatives | |
DK0508191T3 (da) | Fremgangsmåde til fremstilling af 1-carbamoyl-pyrazoler | |
DE69013994D1 (de) | Aromatische und heteroaromatische Amine zur Behandlung von Depressionen, Hirnleistungsstörungen und Dementia. | |
NZ219623A (en) | N-(heterocyclic-substituted phenyl)-n'-benzoylurea derivatives and pesticidal compositions | |
SE8700212L (sv) | Forfarande for framstellning av hns ii | |
FI102537B (fi) | Dehalogenointimenetelmä 3-aroyyli-2-oksindoli-1-karboksiamidien valmis tamiseksi | |
CA2024800A1 (en) | Process for improvement of the flowability of solid cyanuric chloride | |
ATE112284T1 (de) | Exo-3'-4'-o-benzyliden-3''-demethylchartreusin und seine salze. | |
DK632187A (da) | Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater | |
DK93884A (da) | Fremgangsmaade til fremstilling af 1,5-dibeskyttede-1,5,10-triazadecaner, mellemprodukter derfor samt disses fremstilling | |
TH1941A (th) | อนุพันธ์ของไตรอาซีนที่เป็นสารกำจัวัชชพืชและสารตัวกลางที่พัฒนาขึ้นเพื่อใช้ในการผลิตอนุพันธุ์ดังกล่าว |